A landmark trial has found that low-dose peanut oral immunotherapy safely desensitised more than 82% of preschool children ...

UNDATED (WKRC) - Richard Lassiter, a 44-year-old with a severe peanut allergy, can now eat peanuts daily after participating in a "life-changing" desensitization trial. The trial gradually exposed 18 ...

A low-dose peanut oral immunotherapy (OIT) protocol using parent-measured dosing can desensitize children aged 1-4 years with peanut allergy. The approach appears to be acceptably safe and may yield ...

Oral immunotherapy (pOIT) significantly increases peanut challenge tolerance in children compared to avoidance, with 74% success in the pOIT group versus 11% in the avoidance group. The study ...

Innovation is critical for success in the healthcare industry. A key step to that success is the evaluation of new therapies. Managers need to understand the commercial potential of ideas and invest ...

It’s a nut-so miracle! For two British men, peanuts used to be a death sentence. Now? They’re a morning snack. Both suffered from lifelong peanut allergies that had sent them to the hospital before ...

WASHINGTON, D.C. – The Food and Drug Administration (FDA) has approved the first treatment for children with peanut allergies. Allergy experts say Aimmune Therapeutics' Palforzia promises to lower the ...

An expert panel sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, issued clinical guidelines today to aid health care providers ...

Peanut allergy breakthrough as researchers find way to treat children’ - ...

Sofia was just a few months old when she suffered her first allergic reaction to peanuts. "I was eating peanut butter on toast," her mother Sam remembered. "She was sat in her high chair, she picked ...

Aimmune Therapeutics is teaming with Regeneron Pharmaceuticals in hopes of developing a cure for peanut allergies. Aimmune, based in Brisbane, California, specializes in food allergy treatments and ...

McLEAN, Va., Feb. 25, 2026 /PRNewswire/ -- FARE (Food Allergy Research & Education), the leading charity that supports the food allergy community through advocacy, research, and education, today ...